New hope for advanced GIST: experimental drug NB003 takes on resistant tumors
NCT ID NCT07379047
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests an experimental drug called NB003 in people with advanced GIST that has worsened after standard treatments. The trial has two parts: one compares NB003 to the approved drug regorafenib as a third-line therapy, and the other tests NB003 alone as a second-line therapy. The goal is to see if NB003 can shrink tumors or delay cancer growth.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- NB003 (a drug taken by mouth)
- What this could lead to
- If successful, NB003 could offer a new treatment option for people with advanced GIST whose cancer has stopped responding to other drugs.
- What could go wrong
- This is an early-to-mid-stage trial, so NB003 may not work better than existing treatments or could have unexpected side effects. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asan Medical Center
NOT_YET_RECRUITINGSeoul, South Korea
-
Beijing Cancer Hospital
RECRUITINGBeijing, Beijing Municipality, China
-
Cancer Hospital Affiliated to Harbin Medical University
NOT_YET_RECRUITINGHarbin, Heilongjiang, China
-
Fudan University Shanghai Cancer Center
NOT_YET_RECRUITINGShanghai, Shanghai Municipality, China
-
Guangxi Medical University Affiliated Cancer Hospital
NOT_YET_RECRUITINGNanning, Guangxi, China
-
Henan Cancer Hospital
NOT_YET_RECRUITINGZhengzhou, Henan, China
-
Hubei Cancer Hospital
NOT_YET_RECRUITINGWuhan, Hubei, China
-
Jiangsu Cancer Hospital
NOT_YET_RECRUITINGNanjing, Jiangsu, China
-
Jiangsu Province Hospital
NOT_YET_RECRUITINGNanjing, Jiangsu, China
-
Jilin Cancer Hospital
NOT_YET_RECRUITINGChangchun, Jilin, China
-
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
NOT_YET_RECRUITINGShanghai, Shanghai Municipality, China
-
Samsung Medical Center
NOT_YET_RECRUITINGSeoul, South Korea
-
Shandong Cancer Hospital
NOT_YET_RECRUITINGJinan, Shandong, China
-
Shandong Provincial Hospital
NOT_YET_RECRUITINGJinan, Shandong, China
-
Shanxi Cancer Hospital
NOT_YET_RECRUITINGTaiyuan, Shanxi, China
-
Sichuan Cancer Hospital
NOT_YET_RECRUITINGChengdu, Sichuan, China
-
Sir Run Run Shaw Hospital , affiliated with the Zhejiang University School of Medicine
NOT_YET_RECRUITINGHangzhou, Zhejiang, China
-
Sun Yat-sen University Cancer Center
NOT_YET_RECRUITINGGuangzhou, Guangdong, China
-
The Affiliated Hospital of Guizhou Medical University
NOT_YET_RECRUITINGGuiyang, Guizhou, China
-
The Affiliated Hospital of Qingdao University
RECRUITINGQingdao, Shandong, China
-
The First Affiliated Hospital of Anhui Medical University
NOT_YET_RECRUITINGHefei, Anhui, China
-
The First Affiliated Hospital of Chongqing Medical University
NOT_YET_RECRUITINGChongqing, Chongqing Municipality, China
-
The First Affiliated Hospital of Fujian Medical University
NOT_YET_RECRUITINGFuzhou, Fujian, China
-
The First Affiliated Hospital of Nanchang University
NOT_YET_RECRUITINGNanchang, Jiangxi, China
-
The First Affiliated Hospital of Sun Yat-sen University
NOT_YET_RECRUITINGGuangzhou, Guandong, China
-
The First Affiliated Hospital of Zhejiang University School of Medicine
NOT_YET_RECRUITINGHangzhou, Zhejiang, China
-
The First Affiliated Hospital of Zhengzhou University
NOT_YET_RECRUITINGZhengzhou, Henan, China
-
The Fourth Hospital of Hebei Medical University
NOT_YET_RECRUITINGShijiazhuang, Hebei, China
-
The Second Hospital of Anhui Medical University
RECRUITINGHefei, Anhui, China
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, China
-
West China Hospital of Sichuan University
NOT_YET_RECRUITINGChengdu, Sichuan, China
-
Xiangya Hospital, Central South University
NOT_YET_RECRUITINGChangsha, Hunan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive GIST registry aims to unlock secrets of rare cancer
- Custom-Made vaccine aims to boost immune attack on kidney tumors
- New Two-Tooth clip aims to make stomach tumor removal safer and faster
- New drug combo shows promise for Hard-to-Treat stomach cancer
- New hope for GIST: experimental combo targets hard-to-treat tumors
- New hope for advanced stomach cancer: experimental combo targets tumors after first-line failure